142 related articles for article (PubMed ID: 9813898)
21. Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment.
Lin HC; Wang PW; Yang YH; Tsai JJ; Yen CF
J Addict Dis; 2016; 35(2):109-18. PubMed ID: 26670167
[TBL] [Abstract][Full Text] [Related]
22. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.
Huang YF; Kuo HS; Lew-Ting CY; Tian F; Yang CH; Tsai TI; Gange SJ; Nelson KE
Addiction; 2011 Aug; 106(8):1437-45. PubMed ID: 21438941
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.
Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J;
Int J Drug Policy; 2018 Apr; 54():18-25. PubMed ID: 29367011
[TBL] [Abstract][Full Text] [Related]
24. [Little HIV risk behavior in drug users during detention in Dutch penitentiaries].
van Haastrecht HJ; Bax JS; van den Hoek JA
Ned Tijdschr Geneeskd; 1997 Mar; 141(9):429-33. PubMed ID: 9173303
[TBL] [Abstract][Full Text] [Related]
25. Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment.
Darke S; Baker A; Dixon J; Wodak A; Heather N
Drug Alcohol Depend; 1992 Feb; 29(3):263-8. PubMed ID: 1559433
[TBL] [Abstract][Full Text] [Related]
26. Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients.
Drake S; Swift W; Hall W; Ross M
Drug Alcohol Depend; 1993 Dec; 34(1):67-70. PubMed ID: 7909749
[TBL] [Abstract][Full Text] [Related]
27. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.
Nunn A; Zaller N; Dickman S; Trimbur C; Nijhawan A; Rich JD
Drug Alcohol Depend; 2009 Nov; 105(1-2):83-8. PubMed ID: 19625142
[TBL] [Abstract][Full Text] [Related]
28. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
Larney S; Toson B; Burns L; Dolan K
Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
[TBL] [Abstract][Full Text] [Related]
29. Trends in HIV risk behaviour and methadone dosage among HIV-negative drug users: an ecological study.
Langendam MW; van Brussel GH; Coutinho RA; van Ameijden EJ
AIDS; 2000 Aug; 14(12):1870-2. PubMed ID: 10985334
[No Abstract] [Full Text] [Related]
30. Methadone maintenance treatment reduces heroin injection in New South Wales prisons.
Dolan KA; Wodak AD; Hall WD
Drug Alcohol Rev; 1998 Jun; 17(2):153-8. PubMed ID: 16203480
[TBL] [Abstract][Full Text] [Related]
31. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons.
van Haastrecht HJ; Bax JS; van den Hoek AA
Addiction; 1998 Sep; 93(9):1417-25. PubMed ID: 9926547
[TBL] [Abstract][Full Text] [Related]
32. Hair analysis underestimates heroin use in prisoners.
Shearer J; White B; Gilmour S; Wodak AD; Dolan KA
Drug Alcohol Rev; 2006 Sep; 25(5):425-31. PubMed ID: 16939937
[TBL] [Abstract][Full Text] [Related]
33. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
[TBL] [Abstract][Full Text] [Related]
34. Methadone injecting in Australia: a tale of two cities.
Lintzeris N; Lenné M; Ritter A
Addiction; 1999 Aug; 94(8):1175-8. PubMed ID: 10615732
[TBL] [Abstract][Full Text] [Related]
35. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
Lafferty L; Rance J; Treloar C
Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S
Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033
[TBL] [Abstract][Full Text] [Related]
37. Injecting drug use in prison: prevalence and implications for needle exchange policy.
Wright NM; Tompkins CN; Farragher TM
Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704
[TBL] [Abstract][Full Text] [Related]
38. [Heroin abuse among Danish prisoners on remand. I. Prevalence related to form of administration].
Andersen HS; Sestoft DM; Lillebaek T; Gabrielsen G
Ugeskr Laeger; 1996 Aug; 158(34):4749-53. PubMed ID: 8801682
[TBL] [Abstract][Full Text] [Related]
39. HIV risk behaviour correlates among injecting drug users in Greek prisons.
Koulierakis G; Gnardellis C; Agrafiotis D; Power KG
Addiction; 2000 Aug; 95(8):1207-16. PubMed ID: 11092068
[TBL] [Abstract][Full Text] [Related]
40. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
Schütz CG; Rapiti E; Vlahov D; Anthony JC
Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
